China NMPA Drug Inspection - Chengdu Hengda Pharmaceutical Co., Ltd. (contracted) Sichuan Jinyaoshi Pharmaceutical Co., Ltd. to manufacture - Sanqi Wound Medicine Tablets
China NMPA drug inspection for Chengdu Hengda Pharmaceutical Co., Ltd. (contracted) Sichuan Jinyaoshi Pharmaceutical Co., Ltd. to manufacture published June 30, 2017. Drug: Sanqi Wound Medicine Tablets. The Shaanxi Provincial Food and Drug Administration (Shaanxi FDA) released an announcement on June 30, 2017, detailing f
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Chengdu Hengda Pharmaceutical Co., Ltd. (contracted) Sichuan Jinyaoshi Pharmaceutical Co., Ltd. to manufacture published June 30, 2017. Drug: Sanqi Wound Medicine Tablets. The Shaanxi Provincial Food and Drug Administration (Shaanxi FDA) released an announcement on June 30, 2017, detailing f
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox